JAMES SCHMIDT: Open Payments
NPI 1336243666 · SAN PEDRO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,705 in 73 payments from 18 companies in 2025. Trend: 2023 $1,485 · 2024 $1,633 · 2025 $1,705
Food & beverage: $1,705
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $415 |
| Amgen Inc. | 13 | $318 |
| ABBVIE INC. | 13 | $218 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $139 |
| GlaxoSmithKline, LLC. | 3 | $82 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $68 |
| Merck Sharp & Dohme LLC | 3 | $68 |
| SCILEX PHARMACEUTICALS INC. | 3 | $66 |
| PFIZER INC. | 3 | $56 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $54 |
Products named: OTEZLA, FARXIGA, AIRSUPRA, JARDIANCE, BREZTRI, VRAYLAR, TRELEGY ELLIPTA, CAPLYTA.
Industry payments across CA — which companies pay providers there.
